心臓発作ショック: 最先端のレビュー
Aaron Samuels1, Tetiana Zolotarova2, Mark J Eisenberg3
1Department of Medicine, McGill University, Montreal, Canada.
The American journal of cardiology
|February 18, 2026
まとめ
心臓発作ショック治療は進化しており,新しい治療法と標準化された分類により生存率が向上しています. 現在,重点は,この重大な心血管疾患の緊急事態を経験している患者の長期的な回復に焦点を当てています.
科学分野:
- 心血管医学は,心臓血管医学である.
- クリティカルケア・メディシン
背景:
- 心臓発作性ショック,すなわち,組織 perfusion が不十分になるような重度の心機能障害は,重大な心血管の緊急事態です.
- 心臓発作性ショックの病因は,過去20年間にわたって,主として不血性から,心不全のような非不血性原因へと移行した.
- 進化する分類システム (SCAI 段階,SHOCK-ARCF) は,標準化された診断とリスクの階層化に役立ちます.
研究 の 目的:
- 心臓発作ショック管理の発展を振り返る.
- 診断,リスク分層化,治療戦略の進歩を強調する.
- 長期的な生存への焦点転換について議論する.
主な方法:
- 診断とリスクの階層化のための現代の分類システムのレビュー.
- 薬剤療法,再血管化,および循環器の機械的なサポートを含む伝統的なおよび現代的な管理戦略の分析.
- 多分野ショックチームやICU解放バンドルのようなシステムレベルの改善の検討.
主要な成果:
- 標準化された分類システムは,診断とリスクの階層化を改善しました.
- 機械的なサポートやチームベースのケアを含む管理の進歩は,入院死亡率の減少につながりました.
- 早期のアウトカムが改善し,生存率への移行を促した.
結論:
- 現代の管理戦略とシステムレベルの改善により,心臓病性ショックによる入院死亡率が著しく低下しています.
- 介護の焦点は,急性管理から,生存者の長期的な身体的,認知的,心理的なニーズに対処することへと移行しています.
- 有意義で独立した生活を保証することは,心臓病性ショック生存の新しい目標です.
関連する概念動画
Cardiopulmonary Resuscitation IV: Pharmacological Management
937
Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
937
Cardiomyopathy II: Dilated Cardiomyopathy
622
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
622
Introduction Cardiac Emergencies
395
Cardiac emergencies are critical situations involving the heart that require immediate medical intervention to prevent severe complications or death. These emergencies often arise from underlying heart conditions that impair the heart's ability to function correctly.Types of Cardiac EmergenciesThe most common types of cardiac emergencies include Acute Coronary Syndrome (ACS), myocardial infarction (MI), cardiac arrest, and heart failure.Acute Coronary Syndrome (ACS)Acute Coronary Syndrome (ACS)...
395
Blood Pressure Imbalances and Circulatory Shock
1.7K
Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
1.7K
Cardiomyopathy V: Interprofessional Care
493
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
493
Cardiomyopathy III: Hypertrophic Cardiomyopathy
540
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
540


